Adriamycin in the treatment of far-advanced lung cancer
- PMID: 1009526
Item in Clipboard
Adriamycin in the treatment of far-advanced lung cancer
Cancer Treat Rep.
1976 Jul.
No abstract available
Similar articles
-
ICRF-159 versus polychemotherapy in non-small cell lung cancer.Cancer Treat Rep. 1976 Jul;60(7):947-8. Cancer Treat Rep. 1976. PMID: 64297 Clinical Trial. No abstract available.
-
Melphalan versus adriamycin in the treatment of advanced carcinoma of the ovary.Surg Gynecol Obstet. 1975 Dec;141(6):899-902. Surg Gynecol Obstet. 1975. PMID: 1103333 Clinical Trial.
-
Phase II trial of 4'-deoxydoxorubicin in advanced non-small cell lung cancer.Cancer Treat Rep. 1987 Sep;71(9):861-2. Cancer Treat Rep. 1987. PMID: 3040246 No abstract available.
-
Adriamycin therapy for advanced ovarian carcinoma recurrent after chemotherapy.Cancer Treat Rep. 1978 Sep;62(9):1375-7. Cancer Treat Rep. 1978. PMID: 688281 No abstract available.
-
Phase II trial of esorubicin in patients with advanced non-small cell lung cancer.Cancer Treat Rep. 1987 Jul-Aug;71(7-8):783-4. Cancer Treat Rep. 1987. PMID: 3038319 No abstract available.
Cited by
-
Chemotherapy in non-small cell bronchial carcinoma.Thorax. 1985 Sep;40(9):641-5. doi: 10.1136/thx.40.9.641. Thorax. 1985. PMID: 4060103 Free PMC article. No abstract available.
-
Single-agent chemotherapy for advanced adenocarcinoma of the lung. A review.Cancer Chemother Pharmacol. 1988;21(2):89-102. doi: 10.1007/BF00257354. Cancer Chemother Pharmacol. 1988. PMID: 3280154 Review.